
Astegolimab
CAS No. 2173054-79-8
Astegolimab( —— )
Catalog No. M36770 CAS No. 2173054-79-8
Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 360 | Get Quote |
![]() ![]() |
5MG | 610 | Get Quote |
![]() ![]() |
10MG | 938 | Get Quote |
![]() ![]() |
25MG | 1398 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
100MG | 2493 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAstegolimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionAstegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.
-
DescriptionAstegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorInterleukin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2173054-79-8
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Steven G Kelsen, et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. J Allergy Clin Immunol. 2021 Sep;148(3):790-798.?
molnova catalog



related products
-
(E)-dec-3-enoic acid
(E)-dec-3-enoic acid (trans-3-decenoic acid) participates in the production of nanomaterials and can be used to study neurological diseases.
-
Anemarrhenasaponin I
Anemarrhenasaponin I shows the remarkable inhibiting effect on platelet aggregation.
-
HDAOS
HDAOS is a novel Trinder's reagent and is widely used in diagnostic tests and biochemical tests.